ArteraAI

@arteraAI

A leading precision medicine company, ArteraAI develops AI-enabled tests to help personalize therapy for cancer patients.

Menlo Park, CA artera.ai Joined February 2022

156 Following 640 Followers 698 Posts

Latest posts 5

Pinned post

ArteraAI @arteraAI Jan 9

Dr. Daniel Spratt on Artera’s Post‑RP test:

“[It] uses clinical and pathologic features + digital pathology, running AI to help ID patients at low vs high risk of recurrence and metastasis.”

Thanks @UroTimes + Hannah Clarke for the feature.

heyor.ca/mI71pa

#ArteraAI

www.urologytimes.com Daniel Spratt, MD, on using ArteraAI to guide salvage therapy decisions | Urology Times Daniel Spratt, MD, discusses how the ArteraAI Prostate Test (Post-RP) could help guide treatment intensification decisions.

ArteraAI @arteraAI 1d

That's a wrap on #LUGPA2026!

Thank you to everyone who connected with the Artera team in Chicago. We enjoyed the conversations and the opportunity to exchange ideas with the urology community.

ArteraAI @arteraAI 4d

The future of AI in cancer care depends on more than better algorithms.

In @TheAIJournal1, Artera explores why rigorous validation, real-world reliability, and strong clinical evidence are essential to responsible AI adoption.

Read the full article: buff.ly/RDYa0b7

ArteraAI @arteraAI 6d

What could precision medicine look like in five years?

On PathPulse, Artera's Laura Chang shares her vision for expanding AI-powered biomarkers across diseases and making them more accessible worldwide.

Watch the interview: buff.ly/Gnc0ySa

@LumeaDigital

ArteraAI @arteraAI Nov 2

The Artera team is heading to the @ChiUroSociety November 4 meeting!

We look forward to connecting with colleagues and discussing advances in prostate cancer care.

See you there!

#ArteraOnTheGo